Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.08.026

Elif Hindié, Christophe Champion, Clément Morgat
European Urology. 2024-04-01; :
DOI: 10.1016/j.eururo.2024.02.030

PubMed

Lire sur PubMed

1. Eur Urol. 2024 Apr 20:S0302-2838(24)02310-8. doi:
10.1016/j.eururo.2024.02.030. Online ahead of print.

Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering
[(177)Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk
Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2
Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.08.026.

Hindié E(1), Champion C(2), Morgat C(3).

Author information:
(1)Service de Médecine Nucléaire, CHU Bordeaux, Université de Bordeaux, Talence,
France; Institut Universitaire de France, Paris, France. Electronic address:
.
(2)Centre Lasers Intenses et Applications, Université de Bordeaux-CNRS-CEA,
Talence, France.
(3)Service de Médecine Nucléaire, CHU Bordeaux, Université de Bordeaux, Talence,
France.

DOI: 10.1016/j.eururo.2024.02.030
PMID: 38644143